The five-item Brief-Symptom Rating Scale as a suicide ideation screening instrument for psychiatric inpatients and community residents

The five-item Brief-Symptom Rating Scale as a suicide ideation screening instrument for psychiatric inpatients and community residents

BACKGROUND An efficient screening instrument which can be used in diverse settings to predict suicide in different populations is vital. The aim of this study was to use the five-item Brief Symptom Rating Scale (BSRS-5) as a screening instrument for the prediction of suicide ideation in psychiatric, community and general medical settings. METHODS Five hundred and one psychiatric, 1,040 commun...

Efficient suicide ideation screening for psychiatric inpatients and community residents

Background: An efficient screening instrument which can be used in diverse settings to predict suicide in different populations is vital. The aim of this study was to use the five-item Brief Symptom Rating Scale (BSRS-5) as a screening instrument for the prediction of suicide ideation in psychiatric, community and general medical settings. Methods: Five hundred and one psychiatric, 1,040 commun...

Gender Differences in Military Psychiatric Inpatients Admitted for Suicide Ideation

Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale.

Previous four- and five-factor solutions of the 18-item Brief Psychiatric Rating Scale (BPRS) suggested the possibility of an affective dimension in psychosis. A principal components analysis was used to analyze psychiatric symptom data rated on an expanded 24-item version of the BPRS. BPRS data were collected during a period of acute psychotic and affective illness with 114 young adult, recent...

Reanalysing the Brief Psychiatric Rating Scale

For the last 10 years, data have been accumulating indicating that, contrary to former evidence, lithium may play a useful role in the treatment of certain schizophrenic patients. Delva & Letemendia (1982), after reviewing major controlled and uncontrolled studies in this area, concluded that “¿ between one third and one-half of patients with schizophrenia will benefit from lithium―. In two...